Navigation Links
Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman
Date:6/18/2013

New York, New York (PRWEB) June 19, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by dangerous drugs and medical devices, has filed a lawsuit on behalf of an Arizona woman who alleges that she was injured by transvaginal mesh products. The suit was filed on May 30th in the U.S. District Court for the Southern District of West Virginia (Civil Action No. 2:13-cv-12677) in the multidistrict litigation entitled In Re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2325). American Medical Systems, Inc. and Boston Scientific Corporation have been named as Defendants.

According to the Complaint, the Plaintiff was implanted with the MiniArc Sling and the Pinnacle Pelvic Floor Repair Kit in May 2008.The lawsuit alleges that these devices are defective and caused serious and possibly permanent injuries. Furthermore, the Defendants allegedly knew about these defects but did not warn consumers in order to protect their own financial interests.    

AMS and Boston Scientific are being charged with negligence, four counts of strict liability (including design defect, manufacturing defect, failure to warn and defective product) breach of express and implied warranty, fraudulent concealment and constructive fraud. The Plaintiff is suing for pain and suffering, emotional distress, economic loss and is seeking compensation for punitive damages.

Thousands of transvaginal mesh lawsuits have been filed in the United States. Many of them have been consolidated into five MDLs pending in U.S. District Court for the Southern District of West Virginia. The other MDLs include: In Re: Boston Scientific Products Liability Litigation, MDL No. 2326; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; and In Re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327.

According to a June 10th Pretrial Order issued to American Medical Systems, Inc., presentations regarding the selection of Bellwether Cases are to be made on June 25, 2013, with the court expected to select five transvaginal mesh bellwether cases. (http://www.wvsd.uscourts.gov/MDL/amsinc/pdfs/PTO_69.pdf)

Transvaginal mesh devices were approved to treat stress urinary incontinence and pelvic organ prolapse, conditions that are most commonly caused by weakened pelvic muscles. Transvaginal mesh devices are supposed to help correct these conditions by providing additional strength to the pelvic walls. The U.S. Food and Drug Administration (FDA) reports that the most common complications associated with transvaginal mesh may include:    

  •     Mesh erosion through the vagina (also called exposure, extrusion, or protrusion)        
  •     Pain        
  •     Infection        
  •     Bleeding        
  •     Pain during sexual intercourse (dyspareunia)        
  •     Organ perforation        
  •     Urinary problems
(http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm)

The FDA has stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse. The FDA has also asked 33 manufacturers, including Johnson & Johnson, to conduct post-market safety studies in order to investigate the effect of vaginal mesh on organ damage and other health concerns. (http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm)

Recently, the first transvaginal mesh lawsuit to go to trial led to an $11.1 million verdict in favor of the Plaintiff (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey), according to a Feb. 28, 2013, Bloomberg report, which added that Gross’s lawsuit was the first of 4,000 Gynecare Prolift cases expected to go to trial. Johnson & Johnson was ordered to pay $3.35 million in compensatory damages and $7.76 million for punitive damages.(http://www.bloomberg.com/news/2013-02-28/j-j-owes-7-76-million-in-punitives-in-vaginal-mesh-case.html)

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636)

Contact: Parker Waichman LLP
                 Gary Falkowitz, Managing Attorney
                 (800) LAW-INFO
                 (800) 529-4636
                 http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/transvaginalmeshlawsuit/06/prweb10847348.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Leaders in childrens health to gather in Boston
2. Boston researcher, surgical oncologist receives national award
3. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
4. Snoring Isn’t Sexy Member, Dr. Mark Levy attends the American Academy of Dental Sleep Medicine Meeting in Boston, MA
5. Boston University researchers expand synthetic biologys toolkit
6. Cincinnati and Boston Childrens Hospitals receive an NIH Autism Center of Excellence Grant
7. Boston Medical Center awarded elite distinction as a 2012 Leapfrog Top Hospital
8. Boston College researcher looks to stop a deadly parasite in its tracks
9. Northofbostonusa.com Will Release its N5 Fashion Shoes Next Monday
10. Linguists to gather in Boston for National Conference
11. The Boston Eye Group Implants First Intraocular Pressure Transducer for Glaucoma Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: